Insulet Corp. (PODD)
241.26
-4.19
(-1.71%)
USD |
NASDAQ |
Mar 03, 10:55
Insulet Cash from Investing (Quarterly) : -152.80M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -913.00M |
| Intuitive Surgical, Inc. | -209.40M |
| Tandem Diabetes Care, Inc. | -14.98M |
| Boston Scientific Corp. | -512.00M |
| Stryker Corp. | -305.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 183.30M |
| Cash from Financing (Quarterly) | -72.50M |
| Free Cash Flow | 349.90M |
| Free Cash Flow Per Share (Quarterly) | 0.4797 |
| Free Cash Flow to Equity (Quarterly) | 63.30M |
| Free Cash Flow to Firm (Quarterly) | 48.12M |
| Free Cash Flow Yield | 2.03% |